Medications undergo routine testing and verification to ensure correct potency, purity, and consistency before reaching patients
MannKinds inhaled insulin programme, which progressed successfully through phase III clinical testing and gained FDA approval as Afrezza, represents another example of advanced control of particle size, density and dispersibility to enable reliable pulmonary delivery of therapeutics
Many people use it for a year or more to reach and stabilize their goal weight while building sustainable nutrition, activity, and mindset habits
Vomiting and Diarrhea: Some people may experience vomiting or diarrhea, especially in the first few weeks of treatment
In some cases, your healthcare provider might consider alternative weight loss strategies, such as adjusting the GLP-1 medication dosage, prescribing a different drug within the same class, or exploring other weight loss options altogether, like bariatric surgery
Call ahead at +1 (714) 596-1053 to confirm same-day availability